Cost-effectiveness of quantitative fecal lactoferrin assay for diagnosis of symptomatic patients with ileal pouch-anal anastomosis

Journal of Clinical Gastroenterology

Volumn 42, Issue 7, 2008, Pages 799-805

  Parsi, Mansour A ^a   Ellis, Jeffrey J ^b   Lashner, Bret A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Costeffectiveness; Endoscopy; Fecal lactoferrin; Ileal pouch anal anastomosis; Inflammation; Pouchitis; Ulcerative colitis

Indexed keywords

AMITRIPTYLINE; CIPROFLOXACIN; HYDROCORTISONE; HYOSCYAMINE; LACTOFERRIN; MESALAZINE; METRONIDAZOLE; PREDNISONE; ANTIINFECTIVE AGENT;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEFECATION DISORDER; FECES ANALYSIS; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE COST; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; ILEUM POUCH; IRRITABLE POUCH SYNDROME; PRIORITY JOURNAL; ANAL CANAL; ANASTOMOSIS; BIOPSY; CHEMISTRY; COLON POUCH; COST BENEFIT ANALYSIS; CROHN DISEASE; DECISION TREE; ECONOMICS; ENDOSCOPY; FECES; ILEUM;

ANAL CANAL; ANASTOMOSIS, SURGICAL; ANTI-INFECTIVE AGENTS; BIOPSY; COLONIC POUCHES; COST-BENEFIT ANALYSIS; CROHN DISEASE; DECISION TREES; ENDOSCOPY; FECES; HUMANS; ILEUM; LACTOFERRIN; METRONIDAZOLE; POUCHITIS;

EID: 53749097802     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318074fdfe     Document Type: Article

References (26)

1. Parks AG, Nicholls RJ. Proctocolectomy without ileostomy for ulcerative colitis. Br Med J. 1978;2:85-88.
2. Pemberton JH, Kelly KA, Beart RW Jr, et al. Ileal pouch-anal anastomosis for chronic ulcerative colitis. Long-term results. Ann Surg. 1987;206:504-513.
3. Nicholls RJ, Moskowitz RL, Shepherd NA. Restorative proctoco-lectomy with ileal reservoir. Br J Surg. 1985;72:S76-S79.
4. Zuccaro G Jr, Fazio VW, Church JM, et al. Pouch ileitis. Dig Dis Sci. 1989;34:1505-1510.
5. Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology. 1994;107: 1856-1860.
6. Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995;222: 120-127.
7. Curran FT, Hill GL. Symptomatic colitis in the anal canal after restorative proctocolectomy. Aust N Z J Surg. 1992;62:941-943.
8. Lavery IC, Sirimarco MT, Ziv Y, et al. Anal canal inflammation after ileal pouch-anal anastomosis. The need for treatment. Dis Colon Rectum. 1995;38:803-806.
9. Thompson-Fawcett MW, Mortensen NJ, Warren BF. "Cuffitis" and inflammatory changes in the columnar cuff, anal transitional zone, and ileal reservoir after stapled pouch-anal anastomosis. Dis Colon Rectum. 1999;42:348-355.
10. De Oca J, Sanchez-Santos R, Rague JM, et al. Long-term results of ileal pouch-anal anastomosis in Crohn's disease. Inflamm Bowel Dis. 2003;9:171-175.
11. Peyregne V, Francois Y, Gilly FN, et al. Outcome of ileal pouch after secondary diagnosis of Crohn's disease. Int J Colorectal Dis. 2000;15:49-53.
12. Shen B, Achkar JP, Lashner BA, et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol. 2002;97:972-977.
13. Shen B, Achkar JP, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology. 2001;121:261-267.
14. Johansen BG. Isolation of an iron containing red protein from human milk. Acta Chem Scand. 1960;14:510-512.
15. Iyer S, Lonnerdal B. Lactoferrin, lactoferrin receptors and iron metabolism. Eur J Clin Nutr. 1993;47:232-241.
16. Brock J. Lactoferrin: a multifunctional immunoregulatory protein? Immunol Today. 1995;16:417-419.
17. Rado TA, Bollekens J, St Laurent G, et al. Lactoferrin biosynthesis during granulocytopoiesis. Blood. 1984;64:1103-1109.
18. Guerrant RL, Araujo V, Soares E, et al. Measurement of fecal lactoferrin as a marker of fecal leukocytes. J Clin Microbiol. 1992;30: 1238-1242.
19. Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003;98:1309-1314.
20. Parsi MA, Shen B, Achkar JP, et al. Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. Gastroenterology. 2004;126:1280-1286.
21. Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis from chronic ulcerative colitis. Complications and long-term outcome in 1310 patients. Br J Surg. 1998;85:800-803.
22. Hurst RD, Molinari M, Chung TP, et al. Prospective study of the incidence, timing, and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg. 1996;131: 497-502.
23. Madden MV, McIntyre AS, Nicholls RJ. Double-blinded crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci. 1994;39:1193-1196.
24. Shen B, Achkar J-P, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acutepouchitis. Inflamm Bowel Dis. 2001;7:301-305.
25. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119: 305-309.
26. Shen B, Shermock KM, Fazio VW, et al. A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol. 2003;98:2460-2467.